Paul W. Hoelscher has sold HZNP and made no open-market buys since Aug 2019
EVP and CFO at Horizon Therapeutics Public Ltd Co
SEC CIK 0001611468 · Filings on SEC.gov ↗
$0Bought
$62.9MSold
NoneLast buy
Every filing
10 filings since Aug 2019, newest first
HZNPSell
Horizon Therapeutics Public Ltd Co
EVP and CFO
$5.7M−26.0%Apr 22
HZNPSell
Horizon Therapeutics Public Ltd Co
EVP and CFO
$33.8M−69.0%Apr 8
HZNPSell
Horizon Therapeutics Public Ltd Co
EVP and CFO
$4.4M−15.0%Mar 25
HZNPSell
Horizon Therapeutics Public Ltd Co
EVP and CFO
$943K−5.0%Dec 30
HZNPSell
Horizon Therapeutics Public Ltd Co
EVP and CFO
$9.3M−37.0%May 14
HZNPSell
Horizon Therapeutics Public Ltd Co
EVP and CFO
$2.2M−22.0%Aug 25
HZNPSell
Horizon Therapeutics Public Ltd Co
EVP and CFO
$4.0M−44.0%May 7
HZNPSell
Horizon Therapeutics Public Ltd Co
EVP and CFO
$560K−13.0%Oct 17
HZNPSell
Horizon Therapeutics Public Ltd Co
EVP and CFO
$38K−1.0%Sep 4
HZNPSell
Horizon Therapeutics Public Ltd Co
EVP and CFO
$2.0M−31.0%Aug 23
Filings come from SEC EDGAR. Not investment advice.